Subscribe to RSS
DOI: 10.1055/s-0042-118863
Konzept für ein nationales Implantatregister zur Verbesserung der Patientensicherheit
Concept for a National Implant Registry to Improve Patient SafetyPublication History
Publication Date:
09 January 2017 (online)
![](https://www.thieme-connect.de/media/hamipla/201606/lookinside/thumbnails/2016-07-0885_10-1055-s-0042-118863-1.jpg)
Zusammenfassung
Seit Einführung der Silikonimplantate haben mehrere Ereignisse zu einer erheblichen Verunsicherung von Patienten, der Öffentlichkeit und Anwendern geführt. Bislang sind aus keiner der Vorkommnisse hinreichende erforderliche gesetzliche Konsequenzen gezogen worden, um die Patientensicherheit deutlich zu verbessern. Strengere Zulassungen von Medizinprodukten, Kontrollen der Zulassungsstellen und die Novellierung der Medizinprodukte-Betreiberverordnung sind erste Schritte der Politik in die richtige Richtung, reichen jedoch als Frühwarnsystem nicht aus. Nachdem bereits im Koalitionsvertrag die Einführung von Registern angekündigt worden ist, wurde von der Deutschen Gesellschaft der Plastischen-, Ästhetischen und Rekonstruktiven Chirurgen (DGPRÄC) ein Konzept zur Qualitätssicherung im engen Dialog mit dem Gesundheitsministerium erarbeitet, welches hier vorgestellt wird. Das Verlangen nach einem einheitlichen und gesetzlich verpflichtenden zentralen Register für Brustimplantate ist in der Ärzteschaft unstrittig. Nach dem Konzept der DGPRÄC werden drei Datenqualitäten erhoben: Sicherheitsdaten (verpflichtend), Behandlerdaten (freiwillig) und Forschungsdaten (freiwillig, außer sie sind sicherheitsrelevant). Die öffentliche Stelle schafft ein einheitliches, gesichertes Eingabeportal für alle betroffenen Fachgesellschaften. Das Register selbst kann in der jeweiligen Fachgesellschaft angesiedelt sein, von dort werden die Sicherheitsdaten (Pflicht) der öffentlichen Stelle weitergeleitet. Eine Rückentschlüsselung der Identität des Patienten und Behandler erfolgt nur in definierten Notfallsituationen, etwa bei Rückrufaktionen. Automatische Tools in der Sicherheitsdatenbank sorgen für eine frühzeitige Erkennung von Problemen, sodass im Benehmen mit den Fachgesellschaften, Herstellern und ggf. Patienten eine rasche Klärung möglich ist. Das Konzept der DGPRÄC ist in Gesprächen mit den verschiedenen Interessenträgern sehr positiv aufgenommen worden.
Abstract
Since the introduction of silicone implants, several events have led to considerable uncertainty among the patients, public, and users. So far, however, the necessary steps to significantly improving patient safety have not been taken in any of these cases. Requiring stricter approvals for medical devices, improving monitoring by the regulatory authorities and the revision of the Medical Devices Directive are all initial steps in the right direction towards a change in policy, but are insufficient as an early warning system. After the introduction of registers was announced in the coalition agreement, the German Society of Plastic, Aesthetic and Reconstructive Surgeons (DGPRÄC), in close consultation with the Ministry of Health, has developed a concept which is presented here. The need for a uniform and legally binding central register for breast implants is fully supported by the entire medical profession. According to the concept presented by the DGPRÄC, three data qualities would be applicable: Safety data (mandatory), physician information (voluntary) and research data (optional, except if safety related). The public authorities are creating a unified, secure entry portal for all professional associations concerned. This register is based with the professional associations, and from there the mandatory security data will be forwarded to the public authorities. Decoding of the identity of the patient and doctor would only occur in specifically defined emergency situations such as product recalls. Automated tools in the security database provide early detection of problems, so that rapid clarification is possible in consultation with the professional associations, manufacturers and possibly patients. This concept as proposed by the DGPRÄC has thus far been very positively received in all discussions between the various parties concerned.
-
Literatur
- 1 Prantl L, Schreml S, Fichtner-Feigl S et al. Histological and immunohistochemical investigations with capsular contracture after breast augmentation with smooth silicone gel implants. Handchir Mikrochir Plast Chi; 2006 38. 224-232
- 2 Gherardini G, Zaccheddu R, Basoccu G. Trilucent breast implants: Voluntary removal following the Medical Device Agency recommendation. Report on 115 consecutive patients. Plast Reconstr Surg. 2004; 113 (3) 1024-1027
- 3 Brown T, Shearer B. Breast implant registries: A confusion of identities. J Plast Reconstr Aesthet Surg 2015; 68: 1772-1773
- 4 Greco C. The Poly Implant Prothèse breast prostheses scandal: Embodied risk and social suffering. Soc Sci Med 2015; 147: 150-157
- 5 Cooter RD, Barker S, Carroll SM et al. International importance of robust breast device registries. Plast Reconstr Surg 2015; 135: 330-336
- 6 BfArM medical devices: recommendation about possible connection between breast implants and anaplastic large cell lymphoma (ALCL). Available at http://www.bfarm.de/SharedDocs/Risikoinformationen/Medizinprodukte/DE/Brustimplantate_ALCL_FDA.html Accessed March 02, 2016
- 7 US Food and Drug Administration . FDA medical device communication: Reports of anaplastic large cell lymphoma (ALCL) in women with breast implants. Silver Spring, Md: U.S. Food and Drug Administration; 2011. Available at http://www.fda.gov/MedicalDevices/
- 8 Clemens MW, Miranda RN. Coming of Age: Breast Implant-Associated Anaplastic Large Cell Lymphoma After 18 Years of Investigation. Clin Plast Surg 2015; 42: 605-613
- 9 ISAPS International Society of Aesthetic Plastic Surgeons. International Survey on Aesthetic/Cosmetic Procedures Performed in 2014. Available at: http://www.isaps.org/
- 10 Bundesgesetzblatt Jahrgang 2007 Teil I Nr. 5, ausgegeben zu Bonn am 23. Februar 2007: Verordnung zur Änderung medizinprodukterechtlicher Vorschriften 2007; 2007: 2005-2007 Available from http://www.bgbl.de/xaver/bgbl/start.xav?start=%2525252F%2525252F*%25255B%25252540attr_id%2525253D%25252527bgbl107s0155.pdf%25252527%25255D#__bgbl__%2525252F%2525252F*%25255B%25252540attr_id%2525253D%25252527bgbl107s0155.pdf%25252527%25255D__1446822648857 Accessed November 06, 2015
- 11 Bundesgesetzblatt Jahrgang 2014 Teil I Nr. 35, ausgegeben zu Bonn am 28. Juli 2014: Verordnung über die Abgabe von Medizinprodukten und zur Änderung medizinprodukterechtlicher Vorschriften 2014; : 1227-1263 Available from http://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl114s1227.pdf#__bgbl__%25252F%25252F*%255B%252540attr_id%25253D%252527bgbl114s1227.pdf%252527 Accessed February 26, 2016
- 12 Nahabedian MY. Discussion: International importance of robust breast device registries. Plast Reconstr Surg 2015; 135: 337-338
- 13 DGPRÄC_Presseinformation . Ruhende Zulassung von Silimed-Implantaten: Systeme für Patientensicherheit wurden stark verbessert. 25.09.2015. Available from: http://http//www.dgpraec.de/uploads/media/2015-09-25-Silimed_Implantate_01.pdf Accessed March 06, 2016
- 14 Kenkel JM. Discussion: Anaplastic large cell lymphoma and breast implants: a systematic review. Plast Reconstr Surg 2011; 127: 2151-2153
- 15 Kim B, Roth C, Chung KC et al. Anaplastic large cell lymphoma and breast implants: a systematic review. Plast Reconstr Surg 2011; 127: 2141-2150
- 16 Popplewell L, Thomas SH, Huang Q et al. Primary anaplastic large-cell lymphoma associated with breast implants. Leuk Lymphoma 2012; 52: 1481-1487
- 17 Maxwell GP, Gabriel A. The Evolution of Breast Implants. Clin Plast Surg 2009; 36: 1-13
- 18 Champaneria MC, Wong WW, Hill ME et al. The evolution of breast reconstruction: A historical perspective. World J Surg 2012; 36: 730-742
- 19 Keech Jr JA, Anaplastic CB. T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg 1997; 100: 554-555
- 20 De Jong D, De Boer JP, Verhave G. Anaplastic Large-Cell Lymphoma. JAMA 2008; 300: 2030-2035
- 21 McLaughlin JK, Lipworth L, Fryzek JP et al. Long-term cancer risk among Swedish women with cosmetic breast implants: an update of a nationwide study. J Natl Cancer Inst 2006; 98: 557-560
- 22 Kuehlmann B, Prantl L. Breast implants and possible association with ALCL: A retrospective study including a histological analysis of 296 explanted breast tissues and current literature. Clin Hemorheol Microcirc 2016; 63: 439-449
- 23 Park BY, Lee D-H, Lim SY et al. Is late seroma a phenomenon related to textured implants? A report of rare complications and a literature review. Aesthetic Plast Surg 2014; 38: 139-145
- 24 Pinchuk V, Tymofii O. Seroma as a late complication after breast augmentation. Aesthetic Plast Surg 2011; 35: 303-314
- 25 Basile AR, Basile F, Basile AVD. Late infection following breast augmentation with textured silicone gel-filled implants. Aesthetic Surg J 2005; 25: 249-254
- 26 Pittet B, Montandon D, Pittet D. Infection in breast implants. Lancet Infect Dis 2005; 5: 94-106
- 27 Grippaudo FR, Renzi L, Costantino B et al. Late unilateral hematoma after breast reconstruction with implants: case report and literature review. Aesthet Surg J 2013; 33: 830-834
- 28 McArdle B, Layt C. A case of late unilateral hematoma and subsequent late seroma of the breast after bilateral breast augmentation. Aesthetic Plast Surg 2009; 33: 669-670
- 29 Prantl L, Angele P, Schreml S et al. Determination of serum fibrosis indexes in patients with capsular contracture after augmentation with smooth silicone gel implants. Plast Reconstr Surg 2006; 118: 224-229
- 30 Poeppl N, Schreml S, Lichtenegger F et al. Does the surface structure of implants have an impact on the formation of a capsular contracture?. Aesthetic Plast Surg 2007; 31: 133-139
- 31 Chan SC, Birdsell DC, Gradeen Y. Urinary Excretion of Free Toluenediamines in a Patient with Polyurethane-Covered Breast Implants. Clin Chem 1991; 37: 2143-2145
- 32 Flassbeck D, Pfleiderer B, Grümping R et al. Determination of low molecular weight silicones in plasma and blood of women after exposure to silicone breast implants by GC/MS. Anal Chem 2001; 73: 606-611
- 33 Flassbeck D, Pfleiderer B, Klemens P et al. Determination of siloxanes, silicon, and platinum in tissues of women with silicone gel-filled implants. Anal Bioanal Chem 2003; 375: 356-362
- 34 Miranda RN, Aladily TN, Prince HM et al. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol 2014; 32: 114-120
- 35 Adrada BE, Miranda RN, Rauch GM et al. Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients. Breast Cancer Res Treat 2014; 147: 1-14
- 36 Xu J, Wei S. Breast implant-associated anaplastic large cell lymphoma: review of a distinct clinicopathologic entity. Arch Pathol Lab Med 2014; 138: 842-846
- 37 Brody GS, Deapen D, Taylor CR et al. Anaplastic Large Cell Lymphoma Occurring in Women with Breast Implants : Analysis of 173 Cases. Plast Reconstr Surg 2015; 135: 695-705
- 38 Hu H, Jacombs A, Vickery K et al. Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma. Plast Reconstr Surg 2015; 135: 319-329
- 39 Eaves FF, Haeck PC, Rohrich RJ. Breast implants and anaplastic large cell lymphoma: using science to guide our patients and plastic surgeons worldwide. Plast Reconstr Surg 2011; 127: 2501-2503
- 40 Kuehlmann B, Prantl L. Need for a German Breast Implant Registry - Pilot Project Breast Implant Template. Handchir Mikrochir Plast Chir 2016; 48: 199-204